Hemodynamic Response to Intracoronary Infusion of Atrial Natriuretic Factor in Patients with Normal or Altered Left Ventricular function

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  1991-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-199104000-00013PMID 1711628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans.

  1989cited by this paper
• Cardiac effects of atrial natriuretic peptide in subjects with normal left ventricular function.

  1989cited by this paper
• Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men.

  1989cited by this paper
• Atrial Natriuretic Factor Regulates the Calcium Current in Frog Isolated Cardiac Cells

  1988cited by this paper
• h-ANF does not play a role in the regulation of myocardial force of contraction.

  1988cited by this paper
• Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxia.

  1988cited by this paper
• Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure.

  1988cited by this paper
• Atrial Natriuretic Peptide Decreases Cardiac Output Independent of Coronary Vasoconstriction

  1987cited by this paper
• Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.

  1987cited by this paper
• Effects of Atrial Natriuretic Peptide on Proximal Epicardial Coronary Arteries and Coronary Blood Flow in Conscious Dogs

  1987cited by this paper
• Methods of measurement of myocardial blood flow in patients: a critical review.

  1987cited by this paper
• Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension.

  1987cited by this paper
• Inhibition of sympathoadrenal activity by atrial natriuretic factor in dogs.

  1987cited by this paper
• Vagal Mediation of the Effects of Atrial Natriuretic Factor on Blood Pressure and Arterial Baroreflexes in the Rabbit

  1987cited by this paper
• Cardioinhibitory effect of atrial peptide in conscious rats.

  1987cited by this paper
• Cardiac and hemodynamic responses to synthetic atrial natriuretic factor in rats.

  1987cited by this paper
• Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs.

  1986cited by this paper
• Atrial Natriuretic Peptide Decreases Circulatory Capacitance in Areflexic Rats

  1986cited by this paper
• Hemodynamic effects of atrial natriuretic hormone.

  1986cited by this paper
• Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.

  1986cited by this paper
• Coronary vasoconstrictor effects of atriopeptin II.

  1985cited by this paper
• Atriopeptin II lowers cardiac output in conscious sheep.

  1985cited by this paper
• Failure of atriopeptin II to cause arterial vasodilation in the conscious rat.

  1985cited by this paper
• Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.

  1984cited by this paper
• Cardiovascular effects of atrial extracts in anesthetized rats.

  1984cited by this paper
• Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds.

  1984cited by this paper

• The role of natriuretic peptides in regulation of cardiovascular system

  2017cites this paper
• Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure

  2013cites this paper
• Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction.

  2003cites this paper
• Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction.

  1999cites this paper
• [Coronary microcirculation. Physiologic and pathologic aspects].

  1999cites this paper
• Role of cGMP-dependent protein kinase in the negative inotropic effects of cGMP-elevating agents in the mammalian ventricle

  1996influential citation
• Effect of prolonged inhibition of neutral endopeptidase on cardiac hypertrophy in rats with myocardial infarction

  1996cites this paper
• Coronary vascular and endothelial reactivity changes in transgenic mice overexpressing atrial natriuretic factor.

  1996cites this paper
• The natriuretic peptides in heart failure

  1994cites this paper
• Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.

  1994cites this paper
• Atrial contractile performance after cessation of atrial fibrillation.

  1993cites this paper
• Coronary vasodilating action of dobutamine in patients with idiopathic dilated cardiomyopathy.

  1993cites this paper
• Cardiac natriuretic peptides in heart failure.

  1993cites this paper
• Effects of long-term infusion of synthetic atrial natriuretic factor on hemodynamics and water input-output balance in patients with acute myocardial infarction.

  1993cites this paper